The use of recombinant factor VIIa (rVIIa, Novoseven) in the management of surgery and acute bleeding episodes in patients with high responding factor VIII inhibitors

被引:0
|
作者
机构
关键词
Tranexamic Acid; Central Venous Access Device; Novoseven; Bone Marrow Trephine; FVIII Inhibitor;
D O I
10.1007/BF03169824
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors
    Chuansumrit, A
    Sri-Udomporn, N
    Srimuninnimit, V
    Juntarukha, R
    HAEMOPHILIA, 2001, 7 (05) : 532 - 534
  • [42] Health economic review of recombinant activated factor VII (Novoseven®) for treatment of bleeding episodes in hemophilia patients with inhibitors.
    Stephens, Jennifer M.
    Botteman, Marc F.
    Joshi, Ashish V.
    Sumner, Michael
    BLOOD, 2006, 108 (11) : 482B - 482B
  • [43] Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors
    Rocino, Angiola
    Santagostino, Elena
    Mancuso, Maria Elisa
    Mannucci, Pier Mannuccio
    HAEMATOLOGICA, 2006, 91 (04) : 558 - 561
  • [44] Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa
    Eichinger, S.
    Lubsczyk, B.
    Kollars, M.
    Traby, L.
    Zwiauer, K.
    Gleiss, A.
    Quehenberger, P.
    Kyrle, P. A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 707 - 713
  • [45] Recombinant factor VIIa for intraoperative bleeding in a child with hepatoblastoma and review of recombinant activated factor VIIa use in children undergoing surgery
    Al-Said, Khoula
    Anderson, Ronald
    Wong, Andrew
    Le, Doan
    JOURNAL OF PEDIATRIC SURGERY, 2008, 43 (04) : e15 - e19
  • [46] The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications
    Yusim, Yakov
    Peret, Azriel
    Berkenstadt, Haim
    Attia, Moshe
    Knoller, Nachshon
    Sidi, Avner
    JOURNAL OF CLINICAL ANESTHESIA, 2006, 18 (07) : 545 - 551
  • [47] Adjunct use of NovoSeven (recombinant factor VIIa) for penetrating cardiac trauma
    Manuel Garcia-Nunez, Luis
    Enrique Soto-Ortega, Luis
    Cabello-Pasini, Ruy
    Enrique Payro-Hernandez, Luis
    Javier Magana-Sanchez, Ignacio
    CIRUGIA Y CIRUJANOS, 2008, 76 (01): : 95 - 98
  • [48] USE OF RECOMBINANT FACTOR VIIA (RVIIA) IN GLANZMANN THROMBASTHENIA: A SYSTEMATIC REVIEW OF THE LITERATURE
    Samelson-Jones, Ben J.
    Lambert, Michele P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E22 - E22
  • [49] Successful use of recombinant factor VIIa (NovoSeven®) during cardiac surgery in a pediatric patient with congenital factor XI deficiency
    Avci, Zekai
    Malbora, Baris
    Gokdemir, Mahmut
    Ozkan, Suleyman
    Ozbek, Namik
    PEDIATRIC CARDIOLOGY, 2008, 29 (01) : 220 - 222
  • [50] Recombinant factor viia is effective for bleeding and surgery in patients with Glanzmann thrombasthenia
    Nunez, R. J.
    Perez-Garrido, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 888 - 888